Shanghai Medicilon Inc.’s Net Profit Dropped 58.7% in First Three Quarters of 2023

Shanghai Medicilon Inc. (上海美迪西生物医药股份有限公司) (688202.SH) reported a net profit of 114.9 million yuan in the first three quarters of 2023, down 58.7% year-on-year.

Meanwhile, the company posted 1.2 billion yuan in revenue, down 4.6% year-on-year.

At the end of the reporting period, it had 3.6 billion yuan in total assets and 880.2 million yuan in total liabilities, with a liability-to-asset ratio of 24.8%.